Articles by Disease (Glioma)

Histone Deacetylase Inhibitors: A New Wave of Molecular Targeted Anticancer Agents

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 2
Page: 119-134
Author(s): Alfredo Budillon, Elena Di Gennaro, Francesca Bruzzese, Monia Rocco, Giuseppe Manzo and Michele Caraglia

Thalidomide Analogues as Anticancer Drugs

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 2
Page: 167-174
Author(s): Jeanny B. Aragon-Ching, Haiqing Li, Erin R. Gardner and William D. Figg

Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 2
Page: 175-186
Author(s): Constantinos Mikelis, Marina Koutsioumpa and Evangelia Papadimitriou

T11TS/SLFA-3 Differentially Regulate the Population of Microglia and Brain Infiltrating Lymphocytes to Reduce Glioma by Modulating Intrinsic Bcl-2 Expression rather than p53

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 7
Page: 145-155
Author(s): Anirban Ghosh, Joydeep Mukherjee, Malabika Bhattacharjee, Pallab Sarkar, Sagar Acharya and Swapna Chaudhuri

Angiogenesis and Metastasis Inhibitors for the Treatment of Malignant Melanoma

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7
Page: 649-661
Author(s): Riichiro Abe, Yasuyuki Fujita and Sho-ichi Yamagishi

Patents on Immunotoxins and Chimeric Toxins for the Treatment of Cancer

Journal: Recent Patents on Drug Delivery & Formulation
Volume: 1
Page: 105-115
Author(s): Christopher Bachran, Mark Sutherland, Diana Bachran and Hendrik Fuchs

Melatonin and Melatoninergic Drugs as Therapeutic Agents: Ramelteon and Agomelatine, the Two Most Promising Melatonin Receptor Agonists

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume: 1
Page: 142-151
Author(s): Emilio J. Sanchez-Barcelo, Carlos M. Martinez-Campa, Maria D. Mediavilla, Alicia Gonzalez, Carolina Alonso-Gonzalez and Samuel Cos